Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 77.41 | 0.00 | 0.01 | 0.01 |
Short Term Investments | 162.94 | 34.00 | 0.00 | 20.00 |
Cashand Short Term Investments | 240.35 | 38.00 | 4.17 | 29.22 |
Accounts Receivable- Trade Net | 94.31 | 97.31 | 87.92 | 109.39 |
Total Receivables Net | 99.42 | 132.24 | 20.32 | 113.30 |
Total Inventory | 230.31 | 350.24 | 445.33 | 381.10 |
Other Current Assets Total | 1.59 | - | - | 0.00 |
Total Current Assets | 571.66 | 520.83 | 470.17 | 523.89 |
Property/ Plant/ Equipment Total- Net | 240.65 | 233.96 | 232.86 | 233.31 |
Intangibles Net | 8.81 | 10.42 | 12.03 | 13.62 |
Long Term Investments | 16.95 | 5.05 | 5.06 | 5.05 |
Other Long Term Assets Total | 42.16 | 1.04 | 0.69 | - |
Total Assets | 880.23 | 792.80 | 741.91 | 789.51 |
Accounts Payable | 43.30 | 27.74 | 55.09 | 45.23 |
Current Portof LT Debt/ Capital Leases | 105.48 | 0.73 | 0.71 | 1.54 |
Other Currentliabilities Total | 113.67 | 83.91 | 48.20 | 31.36 |
Total Current Liabilities | 262.45 | 216.45 | 196.66 | 173.00 |
Capital Lease Obligations | 4.87 | 0.40 | 0.66 | 0.65 |
Total Long Term Debt | 4.87 | 0.40 | 0.66 | 0.65 |
Total Debt | 110.35 | 105.21 | 92.96 | 96.57 |
Other Liabilities Total | 3.00 | 2.79 | 2.61 | 2.57 |
Total Liabilities | 270.31 | 219.62 | 199.94 | 176.23 |
Common Stock Total | 19.00 | 19.00 | 19.00 | 19.00 |
Retained Earnings( Accumulated Deficit) | 590.91 | 421.27 | 390.08 | 461.22 |
Total Equity | 609.92 | 573.17 | 541.97 | 613.28 |
Total Liabilities Shareholders' Equity | 880.23 | 792.80 | 741.91 | 789.51 |
Total Common Shares Outstanding | 1.90 | 1.90 | 1.90 | 1.90 |
Tangible Book Valueper Share Common Eq | 316.31 | 296.12 | 278.86 | 315.54 |
Cash | - | 3.99 | 4.16 | 9.21 |
Prepaid Expenses | - | 0.36 | 0.35 | 0.28 |
Property/ Plant/ Equipment Total- Gross | - | 253.59 | 251.27 | 251.27 |
Accumulated Depreciation Total | - | -19.64 | -18.40 | -17.96 |
Note Receivable- Long Term | - | 21.50 | 21.10 | 13.64 |
Notes Payable/ Short Term Debt | - | 104.08 | 91.58 | 94.37 |
Minority Interest | - | -0.02 | - | - |
Additional Paid- In Capital | - | 133.50 | 133.50 | 133.50 |
Other Equity Total | - | -0.60 | -0.62 | -0.45 |
Accrued Expenses | - | - | 1.08 | 0.49 |
Nath Bio Genes India Dividend Nath Bio Genes India Bonus Nath Bio Genes India News Nath Bio Genes India AGM Nath Bio Genes India Rights Nath Bio Genes India Splits Nath Bio Genes India Board Meetings Nath Bio Genes India Key Metrics Nath Bio Genes India Shareholdings Nath Bio Genes India Profit Loss Nath Bio Genes India Cashflow Nath Bio Genes India Q1 Results Nath Bio Genes India Q2 Results Nath Bio Genes India Q3 Results Nath Bio Genes India Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks